_id
69105e98ccc777a4e85d592e
Ticker
DYNT
Name
Dynatronics Corporation
Exchange
NASDAQ
Address
1200 Trapp Road, Eagan, MN, United States, 55121
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://www.dynatronics.com
Description
Dynatronics Corporation, a medical device company, designs, develops, manufactures, markets, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States, Asia, Latin America, the Middle East, and internationally. It offers orthopedic soft bracing products, including cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. The company markets its products under the Dynatron, Dynatron Solaris, Bird & Cronin, Hausmann, PROTEAM, and Mammoth brand names. It sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers through a network of independent dealers. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.
Last Close
0.04597
Volume
-
Current Price
0.04
Change
-12.986730476397643
Last Updated
2025-11-29T12:29:24.949Z
Image
data:image/webp;base64,UklGRkgBAABXRUJQVlA4IDwBAAAwBwCdASpAAEAAPrVOn0mnJKKhMfjoAOAWiWUAznyt5uBKghnfjpNqYLgf5VWabB6QJNskaCdxqIrKpxiQKeGOawAA/u6mP/FDzW9g/Qfr1pbmy/2gMTXXucd2adQ695wmfJIv/8NLbKAwySX1X04yKmgdfF5o89u62QCqZ2DUHeu0s3KHZ9gFJ2Ogx3C5j8ee7/Dx+LtLhZ++hEoqVb4Qo7+d8815EsP1Edaor8BVizXu152LZPqt9buX7sP+1x6Krxd2icunuTNLcsIzLBxhBHMqCTgbUEQNYgq1rcizGNwwYgXxlaGdHac2FQ6B8Y6s25Lc1UCl0AKMQjEY0+PEvbKwhx8lDgcMBGc2e5ZMNZsXIbH5vwIosvyYQdP5qvnPVKI4KJebX2dop/fjWz8ZkSS9TltFslbMAAAA
Ipo Date
1994-04-25T00:00:00.000Z
Market Cap
717859
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
5
Target Price
4
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
7024027
Cost Of Revenue
5292398
Gross Profit
1731629
Operating Expenses
1820092
Operating Income
-88463
Interest Expense
103366
Pretax Income
-191829
Net Income
-201857
Eps
-0.015486647075733714
Dividends Per Share
-
Shares Outstanding
16048734
Income Tax Expense
10028
EBITDA
123684
Operating Margin
-1.2594342248399673
Total Other Income Expense Net
-103366
Cash
761748
Short Term Investments
-
Receivables
2778325
Inventories
4824123
Total Current Assets
9018155
Property Plant Equipment
4344319
Total Assets
15003901
Payables
3167812
Short Term Debt
3987331
Long Term Debt
-
Total Liabilities
11943554
Equity
3060347
Depreciation
212147
Change In Working Capital
-75698
Cash From Operations
-93317
Capital Expenditures
296
Cash From Investing
-296
Cash From Financing
529017
Net Change In Cash
435404
PE
-
PB
0.17036317777036394
ROE
-6.595886022075274
ROA
-1.3453634491456588
FCF
-93613
Fcf Percent
-0.013327539885595542
Piotroski FScore
1
Health Score
16
Deep Value Investing Score
5.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
3
Net Net Investing Score
2.5
Quality Investing Score
1.5
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
7024027
Quarters > 0 > income Statement > cost Of Revenue
5292398
Quarters > 0 > income Statement > gross Profit
1731629
Quarters > 0 > income Statement > operating Expenses
1820092
Quarters > 0 > income Statement > operating Income
-88463
Quarters > 0 > income Statement > interest Expense
103366
Quarters > 0 > income Statement > pretax Income
-191829
Quarters > 0 > income Statement > net Income
-201857
Quarters > 0 > income Statement > eps
-0.015486647075733714
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
13034261
Quarters > 0 > income Statement > income Tax Expense
10028
Quarters > 0 > income Statement > EBITDA
123684
Quarters > 0 > income Statement > operating Margin
-1.2594342248399673
Quarters > 0 > income Statement > total Other Income Expense Net
-103366
Quarters > 0 > balance Sheet > cash
761748
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
2778325
Quarters > 0 > balance Sheet > inventories
4824123
Quarters > 0 > balance Sheet > total Current Assets
9018155
Quarters > 0 > balance Sheet > property Plant Equipment
4344319
Quarters > 0 > balance Sheet > total Assets
15003901
Quarters > 0 > balance Sheet > payables
3167812
Quarters > 0 > balance Sheet > short Term Debt
3987331
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
11943554
Quarters > 0 > balance Sheet > equity
3060347
Quarters > 0 > cash Flow > net Income
-201857
Quarters > 0 > cash Flow > depreciation
212147
Quarters > 0 > cash Flow > change In Working Capital
-75698
Quarters > 0 > cash Flow > cash From Operations
-93317
Quarters > 0 > cash Flow > capital Expenditures
296
Quarters > 0 > cash Flow > cash From Investing
-296
Quarters > 0 > cash Flow > cash From Financing
529017
Quarters > 0 > cash Flow > net Change In Cash
435404
Quarters > 0 > ratios > PE
-0.015486647075733714
Quarters > 0 > ratios > PB
0.17036317777036394
Quarters > 0 > ratios > ROE
-6.595886022075274
Quarters > 0 > ratios > ROA
-1.3453634491456588
Quarters > 0 > ratios > FCF
-93613
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.013327539885595542
Quarters > 0 > health Score
16
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
6151516
Quarters > 1 > income Statement > cost Of Revenue
5055214
Quarters > 1 > income Statement > gross Profit
1096302
Quarters > 1 > income Statement > operating Expenses
2040624
Quarters > 1 > income Statement > operating Income
-944322
Quarters > 1 > income Statement > interest Expense
95410
Quarters > 1 > income Statement > pretax Income
-999062
Quarters > 1 > income Statement > net Income
-999062
Quarters > 1 > income Statement > eps
-0.11361941586413007
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
8793057
Quarters > 1 > income Statement > income Tax Expense
187977
Quarters > 1 > income Statement > EBITDA
-641720
Quarters > 1 > income Statement > operating Margin
-15.351045173254855
Quarters > 1 > income Statement > total Other Income Expense Net
-54740
Quarters > 1 > balance Sheet > cash
174090
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
3015746
Quarters > 1 > balance Sheet > inventories
5466794
Quarters > 1 > balance Sheet > total Current Assets
9352270
Quarters > 1 > balance Sheet > property Plant Equipment
4068560
Quarters > 1 > balance Sheet > total Assets
23448289
Quarters > 1 > balance Sheet > payables
3699380
Quarters > 1 > balance Sheet > short Term Debt
3236393
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
11425498
Quarters > 1 > balance Sheet > equity
12022791
Quarters > 1 > cash Flow > net Income
-999062
Quarters > 1 > cash Flow > depreciation
261932
Quarters > 1 > cash Flow > change In Working Capital
756971
Quarters > 1 > cash Flow > cash From Operations
-18107
Quarters > 1 > cash Flow > capital Expenditures
19230
Quarters > 1 > cash Flow > cash From Investing
-19230
Quarters > 1 > cash Flow > cash From Financing
-579583
Quarters > 1 > cash Flow > net Change In Cash
-616920
Quarters > 1 > ratios > PE
-0.11361941586413007
Quarters > 1 > ratios > PB
0.029254628147490882
Quarters > 1 > ratios > ROE
-8.309734403600629
Quarters > 1 > ratios > ROA
-4.260703200988353
Quarters > 1 > ratios > FCF
-37337
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.006069560739173888
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
7300225
Quarters > 2 > income Statement > cost Of Revenue
5655705
Quarters > 2 > income Statement > gross Profit
1644520
Quarters > 2 > income Statement > operating Expenses
2311052
Quarters > 2 > income Statement > operating Income
-666532
Quarters > 2 > income Statement > interest Expense
108295
Quarters > 2 > income Statement > pretax Income
-774827
Quarters > 2 > income Statement > net Income
-774827
Quarters > 2 > income Statement > eps
-0.10679074800949286
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
7255563
Quarters > 2 > income Statement > income Tax Expense
185612
Quarters > 2 > income Statement > EBITDA
-401897
Quarters > 2 > income Statement > operating Margin
-9.1302939292967
Quarters > 2 > income Statement > total Other Income Expense Net
-108295
Quarters > 2 > balance Sheet > cash
791010
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
3030057
Quarters > 2 > balance Sheet > inventories
6537981
Quarters > 2 > balance Sheet > total Current Assets
11100204
Quarters > 2 > balance Sheet > property Plant Equipment
4452774
Quarters > 2 > balance Sheet > total Assets
25765316
Quarters > 2 > balance Sheet > payables
3463215
Quarters > 2 > balance Sheet > short Term Debt
3874552
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
12743947
Quarters > 2 > balance Sheet > equity
13021369
Quarters > 2 > cash Flow > net Income
-774827
Quarters > 2 > cash Flow > depreciation
264635
Quarters > 2 > cash Flow > change In Working Capital
-226711
Quarters > 2 > cash Flow > cash From Operations
134067
Quarters > 2 > cash Flow > capital Expenditures
11082
Quarters > 2 > cash Flow > cash From Investing
-11082
Quarters > 2 > cash Flow > cash From Financing
389582
Quarters > 2 > cash Flow > net Change In Cash
512567
Quarters > 2 > ratios > PE
-0.10679074800949286
Quarters > 2 > ratios > PB
0.022288172618409017
Quarters > 2 > ratios > ROE
-5.950426564211489
Quarters > 2 > ratios > ROA
-3.00724819365693
Quarters > 2 > ratios > FCF
122985
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
0.016846741025105392
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
7602249
Quarters > 3 > income Statement > cost Of Revenue
5621442
Quarters > 3 > income Statement > gross Profit
1980807
Quarters > 3 > income Statement > operating Expenses
2231803
Quarters > 3 > income Statement > operating Income
-250996
Quarters > 3 > income Statement > interest Expense
106348
Quarters > 3 > income Statement > pretax Income
-357344
Quarters > 3 > income Statement > net Income
-366648
Quarters > 3 > income Statement > eps
-0.06224507223116145
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
5890394
Quarters > 3 > income Statement > income Tax Expense
9304
Quarters > 3 > income Statement > EBITDA
58824
Quarters > 3 > income Statement > operating Margin
-3.3016019338487865
Quarters > 3 > income Statement > total Other Income Expense Net
-106348
Quarters > 3 > balance Sheet > cash
278443
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
3568916
Quarters > 3 > balance Sheet > inventories
5471475
Quarters > 3 > balance Sheet > total Current Assets
9831146
Quarters > 3 > balance Sheet > property Plant Equipment
4836280
Quarters > 3 > balance Sheet > total Assets
25064642
Quarters > 3 > balance Sheet > payables
2738921
Quarters > 3 > balance Sheet > short Term Debt
3374258
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
11269646
Quarters > 3 > balance Sheet > equity
13794996
Quarters > 3 > cash Flow > net Income
-366648
Quarters > 3 > cash Flow > depreciation
309820
Quarters > 3 > cash Flow > change In Working Capital
226711
Quarters > 3 > cash Flow > cash From Operations
100646
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-306121
Quarters > 3 > cash Flow > net Change In Cash
-205475
Quarters > 3 > ratios > PE
-0.06224507223116145
Quarters > 3 > ratios > PB
0.017079799080768128
Quarters > 3 > ratios > ROE
-2.6578333186903427
Quarters > 3 > ratios > ROA
-1.4628096423639323
Quarters > 3 > ratios > FCF
100646
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.013238977044819238
Quarters > 3 > health Score
30
Valuation > metrics > PE
-0.015486647075733714
Valuation > metrics > PB
0.17036317777036394
Valuation > final Score
70
Valuation > verdict
83.0% Undervalued
Profitability > metrics > ROE
-6.595886022075274
Profitability > metrics > ROA
-2.238340325709638
Profitability > metrics > Net Margin
-0.02873807290319357
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
3.9026796634499292
Risk > metrics > Interest Coverage
-0.8558229978909893
Risk > final Score
3
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.2603738318018243
Liquidity > metrics > Quick Ratio
0.5861562794761754
Liquidity > final Score
61
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
8
Prev Risks > 1
23
Prev Risks > 2
39
Prev Liquidities > 0
62
Prev Liquidities > 1
69
Prev Liquidities > 2
76
Updated At
2025-12-16T22:35:00.249Z
Dynatronics Corporation, a medical device company, designs, develops, manufactures, markets, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States, Asia, Latin America, the Middle East, and internationally. It offers orthopedic soft bracing products, including cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. The company markets its products under the Dynatron, Dynatron Solaris, Bird & Cronin, Hausmann, PROTEAM, and Mammoth brand names. It sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers through a network of independent dealers. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ADynatronics (NASDAQ:DYNT) Stock Price Passes Below Two Hundred Day Moving Average – Should You Sell? Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$4
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Dynatronics Corporation
1.
SSgA U.S. Total Market Index Strategy(0.0042%)
since
2024/06/30
2.
Renaissance Technologies Corp(0%)
since
2024/09/30
3.
Morgan Stanley - Brokerage Accounts(0%)
since
2024/09/30
4.
Albion Financial Group (Utah)(0%)
since
2024/09/30
5.
BlackRock Inc(0%)
since
2024/09/30
6.
Vanguard Group Inc(0%)
since
2024/09/30
7.
Tower Research Capital LLC(0%)
since
2024/09/30
8.
Sunbelt Securities(0%)
since
2024/09/30
9.
Virtu Financial LLC(0%)
since
2024/09/30
10.
TWO SIGMA SECURITIES, LLC(0%)
since
2024/09/30
11.
Bank of America Corp(0%)
since
2024/09/30
12.
Citadel Advisors Llc(0%)
since
2024/09/30
13.
UBS Group AG(0%)
since
2024/09/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.